Time is the primary evidence-backed intervention. Acute cannabis toxicity follows a self-limiting course, and the clinical ...

AeroDel’s founders, Zahir Jaffer, Shradha Sangwai and K.K.Suraj Rajan, have one common denominator: asthma. This led them to ...

Cannabis oral products appeal to patients who want consistent routines and a clear dose structure for daily symptom support.

Emerging evidence suggests nitrous oxide provides rapid relief for treatment-resistant depression. But is the therapy ready ...

The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...

Peer-reviewed study confirming strong predictive performance of patient-specific lung digital twins, validated against ...

Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...

Launch of albuterol sulfate inhalation aerosol and beclomethasone dipropionate HFA inhalation aerosolBRIDGEWATER, N.J., April 14, 2026 (GLOBE ...

KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ...

Abstract: The Smart Inhaler system presented in this research study integrates two NodeMCU devices to enhance the monitoring and management of respiratory health remotely. The core functionality ...

Going from a medium-dose inhaled corticosteroid to a biologic for asthma led to significant decreases in exacerbations, ...